Ten years of deprescribing guideline work: Where are we now?
作者信息
Farrell Barbara, Famiyeh Ida-Maisie, Preteroti Matthew, Vuong Vincent
机构信息
Senior Scientist at the Bruyère Research Institute in Ottawa, Ont; Assistant Professor in the Department of Family Medicine at the University of Ottawa; and Adjunct Assistant Professor in the School of Pharmacy at the University of Waterloo in Ontario.
Clinical pharmacist at Bruyère Continuing Care in Ottawa and a first-year medical student at the University of Toronto in Ontario.
出版信息
Can Fam Physician. 2023 Oct;69(10):666-669. doi: 10.46747/cfp.6910666.
Abstract
摘要
相似文献
1
Ten years of deprescribing guideline work: Where are we now?
Can Fam Physician. 2023 Oct;69(10):666-669. doi: 10.46747/cfp.6910666.
2
The Role of Patient Preferences in Deprescribing.
Clin Geriatr Med. 2017 May;33(2):165-175. doi: 10.1016/j.cger.2017.01.004. Epub 2017 Feb 23.
3
The effects of in-hospital deprescribing on potential prescribing omission in hospitalized elderly patients with polypharmacy.
Sci Rep. 2021 Apr 26;11(1):8898. doi: 10.1038/s41598-021-88362-w.
4
Deprescribing: Moving beyond barriers and facilitators.
Res Social Adm Pharm. 2022 Mar;18(3):2547-2549. doi: 10.1016/j.sapharm.2021.04.004. Epub 2021 Apr 16.
5
What do older adults with multimorbidity and polypharmacy think about deprescribing? The LESS study - a primary care-based survey.
BMC Geriatr. 2020 Oct 31;20(1):435. doi: 10.1186/s12877-020-01843-x.
6
Targeted Deprescribing in an Outpatient Hemodialysis Unit: A Quality Improvement Study to Decrease Polypharmacy.
Am J Kidney Dis. 2017 Nov;70(5):611-618. doi: 10.1053/j.ajkd.2017.02.374. Epub 2017 Apr 14.
7
Self-efficacy for deprescribing: A survey for health care professionals using evidence-based deprescribing guidelines.
Res Social Adm Pharm. 2018 Jan;14(1):18-25. doi: 10.1016/j.sapharm.2017.01.003. Epub 2017 Jan 28.
8
Attitudes towards deprescribing and the influence of health literacy among older Australians.
Prim Health Care Res Dev. 2019 Jun 20;20:e78. doi: 10.1017/S1463423618000919.
9
Deprescribing in multi-morbid older people with polypharmacy: agreement between STOPPFrail explicit criteria and gold standard deprescribing using 100 standardized clinical cases.
Eur J Clin Pharmacol. 2019 Mar;75(3):427-432. doi: 10.1007/s00228-018-2598-y. Epub 2018 Nov 12.
10
Barriers and enablers for deprescribing among older, multimorbid patients with polypharmacy: an explorative study from Switzerland.
BMC Fam Pract. 2019 May 14;20(1):64. doi: 10.1186/s12875-019-0953-4.
引用本文的文献
1
Proceedings of the Canadian Medication Appropriateness and Deprescribing Network's 2023 National Meeting.
Drug Saf. 2024 Sep;47(9):829-839. doi: 10.1007/s40264-024-01444-2. Epub 2024 Jun 17.
本文引用的文献
1
Survey content validation evaluating the dissemination and implementation of deprescribing guidelines.
Basic Clin Pharmacol Toxicol. 2024 Jan;134(1):63-71. doi: 10.1111/bcpt.13922. Epub 2023 Jul 11.
2
Lessons learned from using whiteboard videos and YouTube for deprescribing guidelines knowledge mobilization.
Int J Pharm Pract. 2022 Nov 4;30(5):441-448. doi: 10.1093/ijpp/riac054.
3
Deprescribing Guidelines: Value of an Interactive Mobile Application.
PRiMER. 2020 Sep 29;4:26. doi: 10.22454/PRiMER.2020.349237. eCollection 2020.
4
Can citation metrics predict the true impact of scientific papers?
FEBS J. 2020 Jun;287(12):2440-2448. doi: 10.1111/febs.15255. Epub 2020 Mar 11.
5
Deprescribing benzodiazepine receptor agonists: Evidence-based clinical practice guideline.
Can Fam Physician. 2018 May;64(5):339-351.
6
Deprescribing antipsychotics for behavioural and psychological symptoms of dementia and insomnia: Evidence-based clinical practice guideline.
Can Fam Physician. 2018 Jan;64(1):17-27.
7
Deprescribing antihyperglycemic agents in older persons: Evidence-based clinical practice guideline.
Can Fam Physician. 2017 Nov;63(11):832-843.
8
Deprescribing proton pump inhibitors: Evidence-based clinical practice guideline.
Can Fam Physician. 2017 May;63(5):354-364.
Zotero 插件